12-63779977-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014254.3(RXYLT1):āc.17A>Gā(p.Lys6Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00019 in 1,610,268 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_014254.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RXYLT1 | NM_014254.3 | c.17A>G | p.Lys6Arg | missense_variant | 1/6 | ENST00000261234.11 | NP_055069.1 | |
RXYLT1 | XM_047428079.1 | c.17A>G | p.Lys6Arg | missense_variant | 1/5 | XP_047284035.1 | ||
RXYLT1 | NM_001278237.2 | c.-1097A>G | 5_prime_UTR_variant | 1/6 | NP_001265166.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RXYLT1 | ENST00000261234.11 | c.17A>G | p.Lys6Arg | missense_variant | 1/6 | 1 | NM_014254.3 | ENSP00000261234 | P1 | |
ENST00000509615.2 | n.238+15504T>C | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152126Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000145 AC: 36AN: 248002Hom.: 0 AF XY: 0.000156 AC XY: 21AN XY: 134420
GnomAD4 exome AF: 0.000198 AC: 289AN: 1458142Hom.: 0 Cov.: 31 AF XY: 0.000214 AC XY: 155AN XY: 725594
GnomAD4 genome AF: 0.000112 AC: 17AN: 152126Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74304
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | May 12, 2023 | BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 16, 2020 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 14, 2022 | This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 6 of the RXYLT1 protein (p.Lys6Arg). This variant is present in population databases (rs145516652, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with RXYLT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 540603). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10 Uncertain:1Other:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
not provided, no classification provided | phenotyping only | GenomeConnect - Invitae Patient Insights Network | - | Variant interpreted as Uncertain significance and reported on 06-14-2021 by Lab Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.17A>G (p.K6R) alteration is located in exon 1 (coding exon 1) of the TMEM5 gene. This alteration results from a A to G substitution at nucleotide position 17, causing the lysine (K) at amino acid position 6 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at